Delhi schools switch to hybrid mode as GRAP stage III curbs take effect; will schools close tomorrow?

India's smartphone market at 5-year high, Apple logs highest-ever quarterly shipments

India poised to become world’s third-largest consumer market by 2026, says report

Are FIIs chasing AI stocks? 4 D-Street triggers already priced in — What’s next?

Gold ETFs attract steady investor demand in October with Rs 7,743 crore net inflows: AMFI data

This IT stock is set to turn into a profit machine; JP Morgan recommends ‘Buy’; check price target

1:10 Stock Split: 100 shares will become 1000 - Do you own this metal stock?

Amit Shah holds another high-level review as NIA takes over Delhi blast case; Red Fort shut for three days: Check traffic curbs issued

Vodafone Idea in Action: Telco in talks with banks & govt after SC relief — Fundraise on horizon?

From Paper Policies to Clicks: Why Indians are buying insurance online 

The&nbsp;approval is a significant milestone for Marksans Pharma in broadening its oncology product line and fortifying its position in the UK pharmaceutical market.&nbsp;Earlier in October, the UK subsidiary received marketing authorisation for the Clonidine 100 microgram tablets and Clonidine Hydrochloride 25 microgram tablets.

Marksans Pharma arm gets nod to market breast cancer drug in UK

Stock of the Day: Today Anil Singhvi gave buying advice in Marksans Pharma. What is stoploss and targets? See in this video.

Stock of the Day: Today Anil Singhvi gave buying advice in Marksans Pharma

Massachusetts Institute of Technology acquired 66 lakh shares of the pharma at an average price of Rs 158 apiece, as per the bulk deal data on the National Stock Exchange (NSE). This took the deal value to Rs 104.28 crore.

&nbsp;

Marksans Pharma soars over 14.65% after MIT buys its 66 lakh shares; multibagger stock has risen over 126% in 1 year 

Marksans Pharma raised ₹372.4 Cr through warrants. Marksans Pharma issued warrants to OrbiMed and the promoters. OrbiMed is a global healthcare investment company.

Breaking News: Marksans Pharma Raised ₹372.4 Cr Through Warrants

Marksans Pharma to double its manufacturing capacity – here’s why? Check analyst view, management’s commentary, share price history and more

The company’s gross profit was at Rs 218.9 crore, growing by over 17 per cent YoY with a gross margin at 50.5 per cent YoY, the pharma company said. &nbsp;

Mukul Agrawal stock: This small-cap pharma company share price zooms 8% – Here’s why 

<h2>In a conversation with Anil Singhvi, Managing Editor at Zee Business, Devanshi Ashar, Research Analyst and Anchor said that from last year Marksans Pharma is witnessing good gains and now the company's board members are going to meet on June 15.</h2>

Marksans Pharma Share Price: What's moving this pharma stocks - know all TRIGGERS here

The company said that USFDA has granted not for an Abbreviated New Drug Application (ANDA) for Loratadine liquid filled capsules 10 mg.

Marksans Pharma shares jump 11% on USFDA nod for allergic drug

marksans-pharma

The approval is a significant milestone for Marksans Pharma in broadening its oncology product line and fortifying its position in the UK pharmaceutical market. Earlier in October, the UK subsidiary received marketing authorisation for the Clonidine 100 microgram tablets and Clonidine Hydrochloride 25 microgram tablets.

Massachusetts Institute of Technology acquired 66 lakh shares of the pharma at an average price of Rs 158 apiece, as per the bulk deal data on the National Stock Exchange (NSE). This took the deal value to Rs 104.28 crore.
 

Marksans Pharma raised ₹372.4 Cr through warrants. Marksans Pharma issued warrants to OrbiMed and the promoters. OrbiMed is a global healthcare investment company.

Zee Business

Home

Personal Finance

India

Economy

Tech

Auto

Markets

Jobs

Indian Railways

World

Videos

Photos

Marksans Pharma News- Zee Business provides latest news on Marksans Pharma, Marksans Pharma news Today, Top News on Marksans Pharma, update on Marksans Pharma Stay updated with business news, breaking news headlines.

Marksans Pharma Latest News- Top News on Marksans Pharma, Update on Marksans Pharma, Marksans Pharma News Today, Breaking News Headlines, Business News | Zee Business

Marksans Pharma

Marksans Pharma arm gets nod to market breast cancer drug in UK

Stock of the Day: Today Anil Singhvi gave buying advice in Marksans Pharma

Marksans Pharma soars over 14.65% after MIT buys its 66 lakh shares; multibagger stock has risen over 126% in 1 year

Breaking News: Marksans Pharma Raised ₹372.4 Cr Through Warrants

Marksans Pharma to double its manufacturing capacity – here’s why? Check analyst view, management’s commentary, share price history and more

Mukul Agrawal stock: This small-cap pharma company share price zooms 8% – Here’s why

RECOMMENDED

Delhi schools switch to hybrid mode as GRAP stage III curbs take effect; will schools close tomorrow?

India's smartphone market at 5-year high, Apple logs highest-ever quarterly shipments

India poised to become world’s third-largest consumer market by 2026, says report

Are FIIs chasing AI stocks? 4 D-Street triggers already priced in — What’s next?

Gold ETFs attract steady investor demand in October with Rs 7,743 crore net inflows: AMFI data

This IT stock is set to turn into a profit machine; JP Morgan recommends ‘Buy’; check price target

1:10 Stock Split: 100 shares will become 1000 - Do you own this metal stock?

Amit Shah holds another high-level review as NIA takes over Delhi blast case; Red Fort shut for three days: Check traffic curbs issued

Vodafone Idea in Action: Telco in talks with banks & govt after SC relief — Fundraise on horizon?

From Paper Policies to Clicks: Why Indians are buying insurance online

Marksans Pharma Share Price: What's moving this pharma stocks - know all TRIGGERS here

Marksans Pharma shares jump 11% on USFDA nod for allergic drug

Top News

Delhi schools switch to hybrid mode as GRAP stage III curbs take effect; will schools close tomorrow?

India's smartphone market at 5-year high, Apple logs highest-ever quarterly shipments

India poised to become world’s third-largest consumer market by 2026, says report

Are FIIs chasing AI stocks? 4 D-Street triggers already priced in — What’s next?

Gold ETFs attract steady investor demand in October with Rs 7,743 crore net inflows: AMFI data

This IT stock is set to turn into a profit machine; JP Morgan recommends ‘Buy’; check price target